drugset / Trial / NCT05484414
Safety and Pharmacokinetics of SAD/MAD Oral Doses of SRP-3D (DA)
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a two-part randomized, double-blind, placebo-controlled study.
Timeline
- Start
- 2025-07-16
- Primary completion
- 2025-12-31
- Completion
- 2026-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SRP-3D (diethylamide) | Unknown | — | Oral |
Indications
No indication recorded.